BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10578372)

  • 1. Interpretation of surveillance kidney allograft biopsies according to the Banff criteria.
    Veronese FV; Gonçalves LF; Edelweiss MI; Manfro RC
    Transplant Proc; 1999 Nov; 31(7):3019-20. PubMed ID: 10578372
    [No Abstract]   [Full Text] [Related]  

  • 2. Allograft instability with frequent acute rejections and early chronic transplant glomerulopathy related to suboptimal doses of cyclosporine A.
    Savin M; Petronic V; Djukanovic L; Dujic A; Stojkovic D; Sindjic M
    Transplant Proc; 1997 Nov; 29(7):2977-9. PubMed ID: 9365636
    [No Abstract]   [Full Text] [Related]  

  • 3. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria.
    Morrissey PE; Gohh R; Shaffer D; Crosson A; Madras PN; Sahyoun AI; Monaco AP
    Transplantation; 1997 Mar; 63(6):845-8. PubMed ID: 9089224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predisposing factors in the development of chronic allograft dysfunction.
    Moray G; Karakayali H; Demirağ A; Köseoğlu F; Akkoç H; Bilgin N; Haberal M
    Transplant Proc; 1999; 31(1-2):1300-1. PubMed ID: 10083580
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of proteinuria in cyclosporine-treated cadaveric renal transplant recipients.
    Koay HC; Vathsala A; Woo KT
    Transplant Proc; 2000 Nov; 32(7):1921-3. PubMed ID: 11120001
    [No Abstract]   [Full Text] [Related]  

  • 6. Can a diagnosis of renal allograft rejection be based on histology alone?
    Midtvedt K; Hartmann A; Sund S
    Clin Transplant; 1998 Aug; 12(4):300-2. PubMed ID: 9686323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protocol biopsies in stable renal transplant patients under triple immunosuppression: results at 6 months.
    Rush DN; Jeffery JR; Gough J
    Transplant Proc; 1994 Oct; 26(5):2576. PubMed ID: 7940797
    [No Abstract]   [Full Text] [Related]  

  • 8. Proteinuria after renal allograft: assessment based on severity and causes.
    Jeong HJ; Kim YS; Oh CK; Park K; Choi IJ
    Transplant Proc; 1994 Aug; 26(4):2132-3. PubMed ID: 8066695
    [No Abstract]   [Full Text] [Related]  

  • 9. Diagnosis of chronic rejection using peritubular and glomerular capillary lesions.
    Morozumi K; Oikawa T; Fukuda M; Sugito K; Takeuchi O; Oda A; Fujinami T; Takeda A; Uchida K
    Transplant Proc; 1996 Feb; 28(1):508-11. PubMed ID: 8644331
    [No Abstract]   [Full Text] [Related]  

  • 10. Follow-up of patients with borderline changes in renal allograft biopsies: clinical outcome and evaluation of other histological features in addition to tubulitis.
    Papadimitriou J; Drachenberg C; Anderson L; Bartlett S; Johnson L; Klassen D; Hoehn-Saric E; Weir M; Schweitzer E
    Transplant Proc; 1996 Feb; 28(1):517-8. PubMed ID: 8644334
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute rejection episodes predict long-term renal transplantation survival.
    Kokado Y; Takahara S; Hatori M; Ichimaru I; Wang JD; Miki T; Okuyama A
    Transplant Proc; 1997; 29(1-2):1537-40. PubMed ID: 9123416
    [No Abstract]   [Full Text] [Related]  

  • 12. Accelerated acute rejection in renal allograft.
    Han DJ; Yoon HS; Lee HM
    Transplant Proc; 1996 Jun; 28(3):1455. PubMed ID: 8658738
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclosporin conversion to CellCept in a cadaveric renal allograft recipient with hemolytic uremic syndrome.
    Said T; al-Mousawi M; Samhan M; Lao M
    Transplant Proc; 1999 Dec; 31(8):3295-7. PubMed ID: 10616482
    [No Abstract]   [Full Text] [Related]  

  • 14. Serial ultrasensitive CRP measurements may be useful in rejection diagnosis after kidney transplantation.
    Oyen O; Wergeland R; Bentdal O; Hartmann A; Brekke IB; Stokke O
    Transplant Proc; 2001 Jun; 33(4):2481-3. PubMed ID: 11406220
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of Banff borderline acute rejection among renal allograft recipients.
    Matoza JR; Danguilan RA; Chicano S
    Transplant Proc; 2008 Sep; 40(7):2303-6. PubMed ID: 18790219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histologic findings in protocol biopsies performed in stable renal allografts under different immunosuppressive schedules.
    Moreso F; Alperovich G; Fulladosa X; Gil-Vernet S; Ibernon M; Carrera M; Castelao AM; Hueso M; Grinyo JM; Serón D
    Transplant Proc; 2003 Aug; 35(5):1666-8. PubMed ID: 12962749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of subclinical rejection on renal allograft histology and function at 6 months.
    Rush D; Jeffery J; Trpkov K; Solez K; Gough J
    Transplant Proc; 1996 Feb; 28(1):494-5. PubMed ID: 8644325
    [No Abstract]   [Full Text] [Related]  

  • 18. Conversion from cyclosporine to tacrolimus in renal allograft recipients with delayed graft function from severe acute tubular necrosis.
    Jang HJ; Kim SC; Han DJ
    Transplant Proc; 2000 Nov; 32(7):1714-5. PubMed ID: 11119904
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of protocol biopsies in the treatment of refractory renal allograft rejection with FK 506.
    Woodle ES; Thistlethwaite JR; Haas M; Josephson MA; Newell KA; Bruce DS; Millis JM; Piper JB; Charette JI
    Transplant Proc; 1996 Apr; 28(2):998-9. PubMed ID: 8623495
    [No Abstract]   [Full Text] [Related]  

  • 20. Kidney transplantation from living donors in Hungary: experience of 22 years.
    Perner F; Hidvégi M; Járay J; Alföldy F; Gyódi E; Petrányi G
    Transplant Proc; 1996 Dec; 28(6):3584-90. PubMed ID: 8962389
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.